Interestingly, some reports showed low frequency of mutation of TGF-β receptor II (TβRII) and other TGF-β pathway genes in HCC, which are often found to be mutationally inactivated in other gastrointestinal cancers [11]–[15]. The gene discussed is TGFBR2; the disease is hepatocellular carcinoma.